
Viva Pharmacology team has years of experience and well-trained experts in a wide variety of platforms and technologies, offering services for DMPK, efficacy study in vitro and in vivo, ranging from assay development for both small molecule and antibody, comprehensive biologics screening, characterization and optimization for drug candidates to DMPK service, efficacy evaluation, pre-tox study and lead preclinical candidate (PCC).
The senior scientists provide the full-spectrum of in vitro and in vivo characterization services including efficacy evaluation of compound, therapeutic monoclonal antibody, bsAb, ADC, CAR-T, and other large molecules for the better treatment of tumor disease, autoimmune condition, inflammatory indication, metabolic disease, diabetes and others.
We also provide high-quality preclinical PK in 5 species, safety, exploratory toxicology, mechanism and biomarker study in vitro and ex vivo to support programs of biotech and pharmaceuticals worldwide.
Senior management team
Experienced scientists with
high quality delivery
Analysis assay lab
Animal facility for mouse, rat and rabbit
Collaborations with academic and partners
Mass spectrum:
Sciex 5500 Qtrap
Sciex 6500+ Triple quadrupole
Sciex7500+ Triple quadrupole
>6000 tests of in vitro ADME assays per year
>400 PK & BBB studies in rodents and dog per year
>50 DRF and Tox studies in rodents per year
Modality including compounds, peptides, Protac, molecular glue, and ADC
CCl4, DMN, TAA-induced liver fibrosis in mice and rats
Bleomycin-induced pulmonary fibrosis in mice
Folic acid-induced kidney fibrosis in mice